Paladin unveils Paladin™ RPG projector – revolutionizing tabletop gaming

Paladin unveils Paladin™ RPG projector - revolutionizing tabletop gaming

Paladin, a leading innovator in tabletop gaming technology, is excited to announce the launch of the Paladin™, a groundbreaking digital projector specifically designed for tabletop role-playing games (RPGs). Developed by a team of passionate RPG enthusiasts, the Paladin™ is set to transform gaming experiences with its state-of-the-art features and exceptional portability.

The Paladin™ seamlessly integrates digital content into RPG sessions, projecting vibrant images, dynamic videos, and intricate battle maps directly onto gaming tables. Enhancing the atmosphere, it also provides immersive soundtracks and stunning visuals from diverse fantasy, futuristic, and horror worlds. This plug-and-play device is user-friendly right out of the box, simplifying setup and enriching storytelling and adventure.

Years of meticulous design and testing, driven by the needs of avid RPG players, culminated in the creation of the Paladin™. Weighing just 700 grams and measuring 13.5cm by 21cm by 8.5cm, its compact size and stylish leather handle make it ideal for portable gaming sessions. Despite its small size, the Paladin™ delivers powerful performance and remarkable versatility.

Advancing the Frontier for Tabletop RPGs

RPG players worldwide have long sought a high-quality, portable device for their games. The Paladin™ meets this demand, offering an unparalleled high-definition experience that is both  versatile and easy to use. Compatible with a wide range of RPGs, including Dungeons & Dragons™, Call of Cthulhu™, Cyberpunk™, Shadowrun™, Warhammer Fantasy Roleplay™, and Pathfinder™, the Paladin™ also works seamlessly with popular Virtual Tabletops (VTTs) like Foundry, Roll20, lets-role, and Owlbear via HDMI connectivity.

Bridging the nostalgic charm of traditional tabletop RPGs with modern digital technology, the Paladin™ supports all major operating systems (iOS, Android, Windows) and features a built-in high-quality audio system, perfect for setting the game’s ambiance. It simplifies the often complex and time-consuming process of integrating digital enhancements, making RPG sessions truly epic.

Join the Paladin™ Community

RPG enthusiasts are invited to join the Paladin™ community for exclusive access to special discounts and insider information. Your support will help bring this transformational project to life. With the Paladin™, there are no limits to the types of content you can display, from NPC illustrations and scene ambiance to videos, scenario evidence, battle maps, and soundtracks.

To learn more of pre-order your own Paladin projector, please visit their campaign, here:

https://www.kickstarter.com/projects/1532861668/paladin-0?ref=e2cs84

About Paladin

Paladin is driven by a profound passion for tabletop role-playing games and is dedicated to developing innovative solutions that enhance the gaming experience. The Paladin™projector is the result of a three-year development journey aimed at creating a device that simplifies digital content integration for RPG sessions.

Media Contact
Company Name: Paladin
City: Paris
Country: France
Website: www.kickstarter.com/projects/1532861668/paladin-0?ref=e2cs84

West Jordan, Utah, Business Attorney Jeremy Eveland Helps Clients Protect Assets, Stay Compliant with Evolving Legal Framework, and Leverage the Tax Code to their Benefit

Eveland helps business clients mitigate risks and make strategic decisions

In the world of business law, every detail must be handled properly to ensure the height of protection and compliance. Jeremy Eveland, a business attorney located in West Jordan, Utah, is at the top of his game when it comes to providing business clients with everything they need to ensure legal safety, compliance, and risk mitigation.

Setting up a business in Utah isn’t particularly difficult, but according to legal experts such as Eveland, setting up a business properly is a complex series of tasks that must be executed to reduce legal liability. When businesses aren’t established properly, their owners are left vulnerable to tax damages, fines, fees, lawsuits, and more.

Eveland’s specialty is helping businesses ensure they are aligned with the law at all times. In doing so, Eveland ensures that his clients avoid various legal issues while staying compliant with various regulations. Furtheremore, Eveland’s clients are able to more easily sign contracts and secure funding. “I don’t offer a cookie cutter service for my clients,” said Eveland. “My specialty is getting to know each client, and by understanding their business, I can pinpoint their legal needs.”

From small businesses to multi-million dollar corporations, Eveland routinely works with entrepreneurs and business owners to ensure that their enterprises are ready for whatever lies ahead. In a time when legal and tax codes change quickly, it’s imperative that business owners and administrators have a lawyer they can trust.

In Eveland’s firm, he offers everything businesses need from the beginning. Establishing the proper legal structure, drafting contracts and agreements, and sifting through laws are services that Eveland proudly provides, and it’s through his one-on-one relationship-oriented approach that his clients benefit the most.

Learn more now by visiting https://jeremyeveland.com/ and https://soundcloud.com/jeremy-eveland/business-lawyer-salt-lake-city-ut-jeremy-elevated-801-613-1472.

ABOUT JEREMY EVELAND

Jeremy Eveland is a leading business, advertising, real estate, and estate planning attorney offering services to a range of individuals, small businesses, larger corporations across Utah. Follow Jeremy on social media: 

Facebook: @attorneyjeremyeveland

Twitter/X: @attyjeremyevlnd

YouTube: @LawyerJeremyEveland

TikTok: @attorneyjeremyeveland

Media Contact
Contact Person: Jeremy Eveland
Email: Send Email
Phone: 801-613-1472
City: WEST JORDAN
State: UTAH
Country: United States
Website: https://jeremyeveland.com/

The Best Choice for Relieving Shoulder Pain: SerenLuna SlumberWing Side Sleeper Pillow

Shoulder pain is a common issue, especially for those who prefer sleeping on their side. Whether it’s due to prolonged poor posture, work-related stress, or sports injuries, shoulder pain can severely affect our sleep quality and overall well-being. In response to this problem, many people seek effective solutions. Among the various options, side sleeper pillows have become an ideal choice for alleviating shoulder pain due to their unique design and remarkable effectiveness.

Causes of Shoulder Pain and Its Impact on Sleep

Shoulder pain can be caused by various factors, including:

  • Muscle Tension and Strain: Prolonged holding of a single posture or repetitive movements can lead to muscle tension and strain in the shoulder.

  • Frozen Shoulder: A common shoulder condition characterized by pain and restricted movement in the shoulder joint.

  • Cervical Spine Issues: Problems in the cervical spine often lead to shoulder pain because the nerves in the neck and shoulder are closely connected.

These issues can negatively impact our sleep. Due to the pain, many people frequently change their sleeping positions, making it difficult to enter deep sleep and causing them to wake up feeling tired and uncomfortable the next day. Side sleeper pillows can effectively alleviate these problems.

What is a Side Sleeper Pillow?

A side sleeper pillow is designed specifically for those who sleep on their side. It usually has a special shape and support structure that provides extra shoulder support, ensuring that the shoulders and spine remain naturally aligned during sleep. This type of pillow not only relieves shoulder pain but also improves overall sleep quality.

How to Choose the Right Side Sleeper Pillow for You

When selecting a side sleeper pillow, there are several key points to consider:

  • Material: Choose high-quality materials like memory foam or natural latex, which offer excellent support and comfort.

  • Height: Select a suitable height based on your sleeping habits and shoulder width. An adjustable-height side sleeper pillow is a great option.

  • Shape Design: Opt for a shape that accommodates your shoulders and head well, ensuring natural alignment during sleep.

  • Breathability: Choose a pillow with good breathability to keep you dry and comfortable throughout the night.


The SerenLuna SlumberWing Pillow
perfectly addresses the needs of side sleepers in terms of material, height, shape design, and breathability. Users can easily enjoy a sleep experience that combines comfort, support, and health.

Design Features and Unique Advantages of the SerenLuna SlumberWing Side Sleeper Pillow

  • Ergonomic Shape

The SerenLuna SlumberWing Pillow boasts an ergonomic design with two distinct zones: a winged side area for extra height needed when side sleeping and a central area for back sleeping, making your head feel like it’s resting on a cloud.

1. Winged Side Area:

The unique butterfly-wing shape increases the height for side sleepers, providing additional support to create a 90-degree angle between the head and shoulders. This alignment ensures the head, neck, and spine are in a straight line, better accommodating the shoulders and evenly distributing pressure across the shoulders and head, thus reducing shoulder strain.

2. Back Sleeping Zone:

The back sleeping zone features a C-curve design, cradling the neck area. Each side of the neck area is filled with materials of different firmness levels, allowing users to choose their preferred neck support and comfort. This ensures optimal ergonomic height, helping users maintain a stable and correct posture during sleep and alleviating neck pain.

3. 3D Structure:

The unique 3D structure of the back sleeping zone stabilizes the head, with a hand rest area allowing users to tuck their hands inside the pillow. The head support zone provides gentle yet firm support, effectively dispersing pressure, ensuring comfort whether lying on the back or side. This design promotes optimal head and neck alignment, prevents discomfort, and maintains proper posture throughout the night, enhancing relaxation and reducing pressure. The hand rest area offers dedicated space for the hands when side sleeping, preventing them from being pressed under the head and causing numbness, enhancing comfort and a sense of security. Additionally, this thoughtful zoning design prevents ear pressure, ensuring a peaceful and refreshing sleep experience.

4. Adjustable Insert:

The pillow core features an adjustable insert that allows for customizable firmness and height, including independent adjustments for each side.

  • High-Quality Materials

The SerenLuna SlumberWing Pillow utilizes 95% high-quality white goose down and 100% natural latex in different zones. The 95% premium white goose down showcases the unparalleled advantages of this luxurious material. Known for its extraordinary softness and excellent thermal insulation, white goose down provides a cloud-like softness, enhancing your sleep experience. The 100% natural latex, in collaboration with TalatexHome, highlights the numerous benefits of this premium latex material. Natural latex is renowned for its exceptional support and comfort, offering elasticity and responsiveness to enhance your sleep experience.

Additionally, the pillowcase of the SerenLuna SlumberWing Pillow is made of high-quality ultra-soft cotton. This innovative material is exceptionally soft and smooth, gentle on the skin. The ultra-soft cotton pillowcase offers luxurious comfort, breathability, hypoallergenic properties, durability, and moisture-wicking benefits.

  • Excellent Breathability

Thanks to the innovative 3cm gusset design and middle layer ventilation system, the SerenLuna SlumberWing Pillow ensures optimal airflow throughout its structure. The 3cm gusset design promotes continuous air circulation, allowing fresh air to flow through the latex, down, and goose down layers. This design effectively prevents heat buildup and avoids discomfort caused by sweating, ensuring a cool and comfortable sleep environment.

  • Antibacterial and Mite-Resistant

The SerenLuna SlumberWing Pillow uses pure down feathers, all of which undergo a 33-step ecological water-washing process. Our proprietary down dust removal technology is patented by our research team. The process includes bio-enzymatic washing, a 10-step feather extraction process, high-pressure sterilization above 120°C, deodorization, removal of heavy metal impurities, a 5-step down dust and iron removal process, and 18 water-washing and sterilization steps. This ensures the pillow has antibacterial and mite-resistant properties, maintaining cleanliness and hygiene for an extended period.

  • Adjustable and Versatile

The adjustable core of the SerenLuna SlumberWing Pillow allows users to customize the firmness and height according to personal preference, enhancing cervical correction and providing optimal support and comfort. For users who find the pillow height and firmness insufficient, we offer adjustable inserts to customize the pillow to meet exact preferences. Users can add up to three inserts to modify the height and firmness as needed.

Each SlumberWing Pillow initially comes with a soft down insert included in the packaging. This insert is filled with pure down and features a 3cm vertical gusset design, ensuring a soft, fluffy feel.

Additionally, we offer a specially designed insert for heavy side sleepers that provides enhanced support where it’s most needed. This insert, made in collaboration with TalatexHome, features natural latex on both sides for superior side-sleeping support, with pure down in the middle to ensure a perfect balance of softness and resilience. If you find the support on both sides insufficient, you can purchase this side-sleeper insert to enhance support.

Another insert option, the three-zone support insert, is more suitable for those needing extra head and neck support. This insert, made of ultra-soft cotton, is divided into three zones. The middle zone has slightly less filling than the top and bottom zones, providing enhanced neck support. If you require extra support while back sleeping, you can easily add this insert.

These three different firmness levels of inserts are available for separate purchase in our additional section. The SerenLuna SlumberWing Pillow’s design helps prevent the formation of rounded shoulders, ensuring users enjoy comfortable sleep while maintaining a healthy posture.

How to Purchase

Sleep is one of the most reliable strategies for enhancing basic human capabilities, and with the SerenLuna SlumberWing Pillow, your body can experience the utmost freedom in movement. All of this is meticulously crafted to meet your needs. SerenLuna, for relaxed shoulders and comfortable neck.

Visit the SerenLuna official website to learn more and purchase your SerenLuna SlumberWing Pillow.

Media Contact
Company Name: Topo Ltd
Contact Person: Romero
Email: Send Email
Country: United Kingdom
Website: https://SerenLunahome.com

Dr. Ebony Stone: Empowering Black Women to Thrive in Corporate America

Dr. Ebony Stone: Empowering Black Women to Thrive in Corporate America

Dr. Ebony Stone is a name synonymous with excellence, resilience, and inspiration. Officially, she wears many hats: corporate executive, entrepreneur, practitioner scholar, leader, mentor, author, speaker, and coach. With a Doctorate of Business Administration and a myriad of other degrees and certifications, her resume is a testament to her relentless pursuit of knowledge and achievement. Yet, if you ask Dr. Stone who she truly is, she will tell you she is just a girl from Detroit, driven by the dream of not only achieving her own success but also helping others like her to do the same.

Over the past two decades, Dr. Stone has led diverse teams across various levels of corporate structures, from entrepreneurial startups to large organizations. This extensive experience has fueled her passion for development, particularly in coaching black women to become their best selves. As a black woman in corporate America, Dr. Stone quickly noticed a glaring lack of representation. She often found herself as the only black woman in the room, navigating challenges and experiences that others could not relate to. This realization ignited her mission to create a supportive space for women embarking on similar corporate journeys.

Dr. Stone’s commitment to her mission is evident in her book, “The Power of the Pause: When a Female Executive Can No Longer Hide Behind High Functioning Anxiety and Depression,” available on her website, on Amazon, and on Audible. The book delves into her personal struggles with anxiety and depression, offering a candid and empowering narrative that encourages women to embrace their vulnerabilities. By sharing her story, Dr. Stone aims to inspire others to own their narratives and find strength in their unique experiences.

In addition to her book, Dr. Stone is a sought-after keynote speaker and workshop facilitator. Her topics include “Power of the Pause,” “Author Your Own Career Narrative,” “Authentic Leadership,” “I’m a Woman – That’s My Superpower,” and “Connecting Purpose to Passion.” Each of these sessions is designed to empower women to lead with authenticity, find their purpose, and connect it to their professional passions.

Dr. Stone’s authenticity, transparency, and candidness set her apart in her niche. As a high-achieving black woman, she understands the pressure to hide imperfections. However, she now recognizes that these so-called imperfections are what make us unique and drive our passions. Dr. Stone’s message to black women is clear: the effort to live up to unrealistic expectations can hinder us from realizing our true potential. Instead, she encourages embracing our journeys’ beauty and greatness, which lies in our authenticity.

Targeting mid-career black women looking to sustain their success without the accompanying burnout, Dr. Stone’s mission is to let them know they are not alone. Through her work, she is building a community of women to support each other on their unique journeys. This community is a place of solace, collaboration, and connection, designed to eradicate loneliness and empower women to shine.

As a dedicated wife and mother, Dr. Stone continues to lead, mentor, coach, and serve in every way she can. Her vision is to create spaces where women can connect, share their stories, and support each other in achieving their dreams. For media inquiries, please contact Shawn Fair at Fair Consulting Group, or visit www.leadershipexperiencetour.com for more information.

In a world where black women in corporate America often feel isolated and pressured to conform, Dr. Ebony Stone is a beacon of hope and empowerment. Her life’s work is a testament to the power of authenticity, community, and relentless pursuit of one’s dreams. Through her book, speaking engagements, and coaching, Dr. Stone is helping black women across the nation to embrace their true selves and reach new heights in their careers.

Media Contact
Company Name: Fair Consulting Group
Contact Person: Shawn Fair
Email: Send Email
Phone: 5866901879
Country: United States
Website: www.leadershipexperiencetour.com

Redodo Prime Day is coming: Get Up to 50% Off on Redodo High Quality Lithium Batteries

Redodo, the industry leader in high-quality lithium iron phosphate batteries, is electrifying Prime Day during July 8th  to July 18th with jaw-dropping discounts of up to 50%. This limited-time offer sets a new standard for value and performance, making it the must-have deal of the season. The excitement doesn’t stop with Prime Day. The Redodo Official Website has a lineup of exclusive activities and benefits that promise to supercharge your experience. Whether you’re an RV off-roading enthusiast or a yacht sailing aficionado, Redodo’s Prime Day extravaganza is set to power your outdoor adventures like never before.

Redodo Prime Day Special Offers – Crazy Lowest Prices Ever  July 16th – July 17th (Support 15-day Lowest Price Guarantee)

  • 12V 50Ah Pro: ONLY $129.99 (Regular $169.99)

  • 12V 100Ah: ONLY $199.99 (Regular $279.99)

  • 12V 100Ah Mini: ONLY $235.99 (Regular $299.99)

  • 12V 100Ah Group 24: ONLY $199.99 (Regular $339.99)

  • 12V 100Ah Trolling Motor: ONLY $204.99 (Regular $339.99)

  • 12V 100Ah Smart Bluetooth: ONLY $239.99 (Regular $339.99)

  • 12V 200Ah: ONLY $415.99 (Regular $519.99)

  • 12V 200Ah Plus: ONLY $439.99 (Regular $569.99)

  • 12V 280Ah Low Temp: ONLY $619.99 (Regular $699.99)

  • 12V 300Ah: ONLY $674.99 (Regular $799.99)

  • 12V 410Ah: ONLY $1119.99 (Regular $1499.99)

  • 24V 100Ah: ONLY $439.99 (Regular $519.99)

  • 24V 200Ah: ONLY $1023.99 (Regular $1499.99)

Experience unmatched Member Day offers with extra rewards on Redodo official website, designed to maximize your savings.

1. Site-Wide Discount Promotion

Enjoy automatic discounts: $15 off orders over $500, $40 off orders over $1,000, and $100 off orders over $2,000 at checkout.

2. Join Redodo Membership and Get Points to Exchange for PrizesAccumulate 500 points to exchange for a set of 250A fuses; accumulate 700 points to exchange for a 300W inverter; accumulate 900 points to exchange for a 250A circuit breaker; accumulate 2000 points to exchange for a 500A battery monitor or 12V 12Ah battery; accumulate 3000 points to exchange for a 14.6V 20A charger or 1000W inverter. (1 point for every 1 USD order)

3. Surprise gift pack limited edition rush sale

  • 12V 100ah Bluetooth battery only $219.99, limited to 5 pieces

  • 12V 100ah mini battery only $199.99, limited to 5 pieces

  • 12V 100ah battery only $189.99, limited to 5 pieces

4.The Ultimate Grand Prize – Lucky Winners Get Free Orders

Redodo Member Day offers unparalleled discounts, and during the Member Day period, there is a chance to win free order grand prizes! This is Redodo’s exclusive way of giving back to you. Come join in the fun!

Redodo 12V 100ah Trolling Motor Battery – Best Trolling Motor Battery

Redodo has launched a specially upgraded 12V 100Ah trolling motor battery, featuring low-temperature charging cutoff protection. The upgraded BMS adds extra precharge function, automatic recovery after protection, and enhanced waterproof and anti-corrosion performance. It supports up to 300A continuous current within 5S and 500A peak current within 3S. This battery guarantees stable performance in any condition, Whether you are sailing on calm or rough waters, you can trust that the Redodo battery will always provide stable performance.

12V 100ah Group24 Battery – Group 24 size fits all RVs

Redodo has upgraded its 12V 100Ah 24 Group Deep Cycle Battery to a smaller size, which is seamlessly compatible with the BCI 24 Group size, making it ideal for various RV battery enclosures – 24/27/31 Group battery boxes. Despite the size reduction, the energy capacity remains unchanged at 1.28kWh, with an over 40% increase in energy density. Compact yet powerful, it provides the energy to fuel your lifestyle. Whether you are embarking on a cross-country road trip or setting up camp in a remote location, the Redodo 12V 100Ah Group 24 Battery is your perfect companion.

12V 100ah Smart Bluetooth Battery – Real-Time Capacity Monitoring

Redodo 12V 100ah Smart Bluetooth battery comes with Smart Bluetooth 5.0, allowing users to link it to the Redodo APP for real-time monitoring of the battery’s comprehensive status and data, such as SOC, charge/discharge/idle state, battery voltage, current, power, remaining capacity, battery temperature, and life cycles. No More Power Anxiety. Track and manage your battery’s performance from your smartphone, ensuring optimal operation and longevity.

12V 100Ah Mini Battery – the Lightest and Smallest Lithium Battery

The Redodo 12V 100Ah Mini Lithium Battery is the ultimate choice for anyone seeking a powerful, compact, and lightweight energy solution. The Redodo 12V 100Ah Mini Lithium Battery measuring only 10.23×5.23×8.95 inches – 35% smaller than the standard 12V 100Ah 31 Group battery. At just 19.84 lbs, it’s 18% lighter than a standard 12V 100Ah battery, yet it still provides the same 1280Wh of energy output! And compared to other 100Ah lead-acid batteries, it’s 69% lighter. Our ultra-compact design ensures you’ll never have to worry about space constraints again.

Redodo is a leading supplier of state-of-the-art deep cycle lithium batteries, consistently using top-tier automotive-grade prismatic lithium iron phosphate cells across our entire battery lineup. This ensures every Redodo lithium battery boasts exceptional durability and lifespan, while also guaranteeing over 101% of the usable capacity.

Moreover, Redodo is committed to delivering an outstanding customer experience. Redodo offers rapid delivery within 2-5 business days, as well as 24-hour after-sales support. Our dedicated team provides personalized online assistance to help you set up your battery system and resolve any issues you may have.

Don’t miss out on the best Prime Day deals and save even more with Extra 5% discount code: PD5.

Media Contact
Company Name: Shenzhen Maicheng Technology Innovation Co., Ltd.
Contact Person: Yvonne, JO
Email: Send Email
Country: China
Website: https://www.redodopower.com/

Bladder Cancer Pipeline 2024 | UroGen Pharma Ltd., Asieris Pharmaceuticals, G1 Therapeutics, Inc., LintonPharm Co. Ltd., Vaxiion Therapeutics, Merck Sharp & Dohme LLC, CG Oncology Inc., Ferring Pharma

DelveInsight’s, “Bladder Cancer Pipeline Insight 2024” report provides comprehensive insights about 80+ companies and 100+ pipeline drugs in the Bladder cancer pipeline landscape. It covers the Bladder Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bladder Cancer pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

Discover the latest drugs and treatment options in the Bladder Cancer Pipeline. Dive into DelveInsight’s comprehensive report today! @ Bladder Cancer Pipeline Outlook

Key Takeaways from the Bladder Cancer Pipeline Report

  • July 2024:- Merck Sharp & Dohme LLC– A Phase 3, Randomized, Double-blind, Placebo-controlled Clinical Trial to Study the Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Chemoradiotherapy (CRT) Versus CRT Alone in Participants With Muscle-invasive Bladder Cancer (MIBC) (KEYNOTE-992)
  • July 2024:- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins-This is a single arm, Phase II trial involving the use of atezolizumab plus platinum and etoposide for patients with locally advanced urothelial cancer. The primary goal of this trial is to assess the pathologic complete response rate at cystectomy in patients after being treated with a combination therapy of atezolizumab, platinum, and etoposide.
  • July 2024:- Hoffmann-La Roche- A Phase III, Double-Blind, Multicenter, Randomized Study of Atezolizumab (Anti-PDL1 Antibody) Versus Placebo as Adjuvant Therapy in Patients With High-Risk Muscle-Invasive Bladder Cancer Who Are ctDNA Positive Following Cystectomy.
  • DelveInsight’s Bladder Cancer pipeline report depicts a robust space with 80+ active players working to develop 100+ pipeline therapies for Bladder Cancer treatment.
  • The leading Bladder Cancer Companies such as UroGen Pharma Ltd., Asieris Pharmaceuticals, G1 Therapeutics, Inc., LintonPharm Co. Ltd., Vaxiion Therapeutics, Merck Sharp & Dohme LLC, CG Oncology, Inc., Ferring Pharmaceuticals, SURGE Therapeutics, Halozyme Therapeutics, ImmunityBio, Inc., AstraZeneca, Spectrum Pharmaceuticals, Inc., enGene, Inc., CicloMed LLC, Protara Therapeutics, Hoffmann-La Roche, Astellas Pharma Global Development, Inc., and Five Prime Therapeutics, Inc., and others.
  • Promising Bladder Cancer Therapies such as Atezolizumab, PGV001, VAX014, BCG Vaccine, Oncofid-P-B, Oncofid-P-B, and others.

Stay ahead with the most recent pipeline outlook for Bladder Cancer. Get insights into clinical trials, emerging therapies, and leading companies with DelveInsight @ Bladder Cancer Treatment Drugs

Bladder cancer Emerging Drugs

UGN-102: UroGen Pharma Ltd.

UGN-102 (mitomycin) for intravesical solution is an investigational drug formulation of mitomycin. It is been developed by utilizing UroGen’s proprietary RTGel® technology which is a sustained release, hydrogel-based formulation, UGN-102 is designed to enable longer exposure of bladder tissue to mitomycin, thereby enabling the treatment of tumors by non-surgical means. UGN-102 is delivered to patients using a standard urinary catheter in an outpatient setting. Currently it is in Phase III stage of clinical trial for the treatment of Bladder Cancer.

APL 1202 : Asieris Pharmaceuticals

APL-1202 is an orally available reversible MetAP2 Inhibitor with anti-angiogenic, anti-tumor activities and can also modulate tumor immune microenvironment. It is currently in registration clinical trials in China, either as single agent as first-line treatment for patients with intermediate-risk non-muscle invasive bladder cancer (NMIBC), or in combination with a chemotherapy as second-line treatment in patients with intermediate and high-risk chemo-refractory NMIBC. Currently, the drug is being evaluated in the Phase III stage for Bladder Cancer.

Trilaciclib: G1 Therapeutics, Inc.

Trilaciclib, is a first-in-class therapy designed to improve outcomes for people with cancer who are treated with chemotherapy. It is a transient IV-administered CDK4/6 inhibitor, a novel therapeutic approach which is given before chemotherapy that temporarily blocks progression through the cell cycle. Currently the drug is being evaluated in Phase II for the treatment of Bladder Cancer.

Catumaxomab: LintonPharm Co.,Ltd.

Catumaxomab is a bispecific antibody that binds to EpCAM (the epithelial cell adhesion molecule) on the tumor cell–and CD3 on the T cell, recruits immune accessory cells through FcγR binding at the same time. The drug kills tumor cells by engaging T cell and accessory cell mediated cytotoxicity and has the potential to induce long-term vaccinal effects which has been verified in animal models. The drug is in Phase I/II stage of clinical trials for the treatment of bladder cancer.

VAX 014: Vaxiion Therapeutics

VAX014 is a novel rBMC-based oncolytic immunotherapy. VAX014is a first-in-class tumor-targeted oncolytic agent based on Vaxiion’s proprietary rBMC technology. It works by specifically targeting and delivering a novel fast-acting pre-formed oncolytic protein toxin directly to tumor cells that express either α3β1 or α5β1 integrin(s), both commonly found to be selectively expressed in many solid tumor types. The drug is in Phase I stage of clinical trials for the treatment of bladder cancer.

Explore groundbreaking therapies and clinical trials in the Bladder Cancer Pipeline. Access DelveInsight’s detailed report now! @ New Bladder Cancer Drugs

Bladder cancer pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration

  • Oral
  • Parenteral
  • Intravenous
  • Subcutaneous
  • Topical

Bladder Cancer Products have been categorized under various Molecule types such as

  • Monoclonal Antibody
  • Peptides
  • Polymer
  • Small molecule
  • Gene therapy

Unveil the future of Bladder Cancer Treatment. Learn about new drugs, pipeline developments, and key companies with DelveInsight’s expert analysis @ Bladder Cancer Market Drivers and Barriers

Scope of the Bladder Cancer Pipeline Report

  • Coverage- Global
  • Bladder Cancer Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
  • Bladder Cancer Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III
  • Bladder Cancer Companies- UroGen Pharma Ltd., Asieris Pharmaceuticals, G1 Therapeutics, Inc., LintonPharm Co. Ltd., Vaxiion Therapeutics, Merck Sharp & Dohme LLC, CG Oncology, Inc., Ferring Pharmaceuticals, SURGE Therapeutics, Halozyme Therapeutics, ImmunityBio, Inc., AstraZeneca, Spectrum Pharmaceuticals, Inc., enGene, Inc., CicloMed LLC, Protara Therapeutics, Hoffmann-La Roche, Astellas Pharma Global Development, Inc., and Five Prime Therapeutics, Inc., and others
  • Bladder Cancer Therapies- Atezolizumab, PGV001, VAX014, BCG Vaccine, Oncofid-P-B, Oncofid-P-B, and others.

Get the latest on Bladder Cancer Therapies and clinical trials. Download DelveInsight’s in-depth pipeline report today! @ Bladder Cancer Companies, Key Products and Unmet Needs

Table of Content

  1. Introduction
  2. Executive Summary
  3. Bladder Cancer : Overview
  4. Pipeline Therapeutics
  5. Therapeutic Assessment
  6. Late Stage Products (Phase III)
  7. UGN-102: UroGen Pharma Ltd.
  8. Drug profiles in the detailed report…..
  9. Mid Stage Products (Phase II)
  10. Trilaciclib: G1 Therapeutics, Inc.
  11. Early Stage Products (Phase I)
  12. VAX 014: Vaxiion Therapeutics
  13. Inactive Products
  14. Bladder Cancer Key Companies
  15. Bladder Cancer Key Products
  16. Bladder Cancer – Unmet Needs
  17. Bladder Cancer – Market Drivers and Barriers
  18. Bladder Cancer – Future Perspectives and Conclusion
  19. Bladder Cancer Analyst Views
  20. Bladder Cancer Key Companies
  21. Appendix

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Media Contact
Company Name: DelveInsight LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: +14699457679
Address:304 S. Jones Blvd #2432,
City: Las Vegas
State: United States
Country: India
Website: https://www.delveinsight.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Bladder Cancer Pipeline 2024 | UroGen Pharma Ltd., Asieris Pharmaceuticals, G1 Therapeutics, Inc., LintonPharm Co. Ltd., Vaxiion Therapeutics, Merck Sharp & Dohme LLC, CG Oncology Inc., Ferring Pharma

Biliary Tract Cancers Pipeline 2024 | Yantai Rongchang Pharmaceutical, RemeGen, EMD Serono, SMT bio Co., Ltd., CSPC ZhongQi Pharmaceutical Technology Co., Ltd., InnoPharmax Inc., Lee’s Pharmaceutical

DelveInsight’s, “Biliary Tract Cancers Pipeline Insight 2024” report provides comprehensive insights about 80+ companies and 80+ pipeline drugs in the Biliary Tract Cancers Pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

Discover the latest drugs and treatment options in the Biliary Tract Cancer Pipeline. Dive into DelveInsight’s comprehensive report today! @ Biliary Tract Cancer Pipeline Outlook

Key Takeaways from the Biliary Tract Cancer Pipeline Report

  • July 2024:- Merck Sharp & Dohme LLC- A Phase 1/2 Study to Evaluate the Safety and Efficacy of MK-2870 Monotherapy or in Combination With Other Anticancer Agents in Gastrointestinal Cancers. Researchers want to learn if sacituzumab tirumotecan (MK-2870) alone or with chemotherapy can treat certain gastrointestinal (GI) cancers. The GI cancers being studied are either advanced (the cancer has spread to other parts of the body), or unresectable (the cancer cannot be removed with surgery).
  • July 2024:- Amgen- A Phase 1/1b/2 Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of AMG 193 Alone and in Combination With Docetaxel in Subjects With Advanced MTAP-null Solid Tumors. The primary objective of Part 3 of this study is to evaluate the efficacy of AMG 193 in adult participants with metastatic or locally advanced MTAP-null solid tumors.
  • DelveInsight’s Biliary Tract Cancer pipeline report depicts a robust space with 80+ active players working to develop 80+ pipeline therapies for treatment.
  • The leading Biliary Tract Cancer Companies such as Yantai Rongchang Pharmaceutical, RemeGen, EMD Serono, SMT bio Co., Ltd., CSPC ZhongQi Pharmaceutical Technology Co., Ltd., InnoPharmax Inc., Lee’s Pharmaceutical Limited, Hoffmann-La Roche, Shanghai Miracogen Inc., Zymeworks Inc., Bristol-Myers Squibb, Eli Lilly and Company, Ipsen, Threshold Pharmaceuticals, Leap Therapeutics, Hutchison Medipharma Limited, Array BioPharma, Redx Pharma Plc, Compass Therapeutics, Lee’s Pharmaceutical Limited, and others.
  • Promising Biliary Tract Cancer Therapies such as Nivolumab, Gemcitabine, and S-1, Gemcitabine, cisplatin, Pembrolizumab, Sargramostim, oxaliplatin, KN035 plus Gemcitabine & oxaliplatin, and others.

Stay ahead with the most recent pipeline outlook for Biliary Tract Cancer. Get insights into clinical trials, emerging therapies, and leading companies with DelveInsight @ Biliary Tract Cancer Treatment Drugs

Biliary Tract Cancer Emerging Drugs Profile

MRG 002: Miracogen

MRG 002, is an antibody-drug conjugate (ADC) composed of a humanized immunoglobulin G1 (IgG1) monoclonal antibody directed against the tumor-associated antigen (TAA) human epidermal growth factor receptor 2 conjugated to the microtubule-disrupting cytotoxic agent monomethyl auristatin E (MMAE), with potential antineoplastic activity. An open-label, single-arm, multi-center, phase II Clinical Study of MRG002 are conducted by Miracogen for the treatment of patients with HER2-positive unresectable, locally advanced or metastatic biliary tract cancer. MRG002 is administrated by an IV infusion of 2.6 mg/kg on Day 1 of every 3 weeks (21-day cycle).

Disitamab vedotin: Yantai Rongchang Pharmaceutical

Disitamab Vedotin is an antibody-drug conjugate with a drug structure consisting of three parts Anti-human epidermal growth factor receptor 2 extracellular domain (HER2 ECD) antibody; Linker (MC-Val-Cit-PAB, Linker); and Cytotoxic Monomethyl Auristatin E (Monomethyl Auristatin E, MMAE). This product is white to light yellow loose body, after reconstitution, it is colorless to light yellow clear liquid.

Envafolimab: Alphamab Oncology

Envafolimab is a PD-L1 single-domain antibody Fc fusion protein independently developed by Alphamab. Based on the unique design, Envafolimab has advantages in safety, convenience and compliance, and can be used for patients who are not suitable for intravenous infusion with a lower medical cost. On March 30, 2020, Alphamab, 3D Medicines and Simcere reached a three-way strategic collaboration. Alphamab, as the original research party, is responsible for production and quality, 3D Medicines is responsible for global clinical development in the field of oncology, registration and commercialization abroad, and Simcere is responsible for the exclusive commercial promotion of the product in mainland China.

DKN-01: Leap Therapeutics

DKN-01 is a humanized monoclonal antibody that binds to and blocks the activity of the Dickkopf-1 (DKK1) protein. DKK1 modulates the Wnt/Beta-catenin and PI3kinase/AKT signaling pathways and has an important role in promoting tumor proliferation, metastasis, angiogenesis, and in mediating an immune suppressive tumor microenvironment through enhancing the activity of myeloid-derived suppressor cells and downregulating NK cell ligands on tumor cells.

Explore groundbreaking therapies and clinical trials in the Biliary Tract Cancer Pipeline. Access DelveInsight’s detailed report now! @ New Biliary Tract Cancer Drugs

Biliary Tract Cancer pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration

  • Intravenous
  • Subcutaneous
  • Oral
  • Intramuscular

Products have been categorized under various Molecule types such as

  • Monoclonal antibody
  • Small molecule
  • Peptide

Unveil the future of Biliary Tract Cancer treatment. Learn about new drugs, pipeline developments, and key companies with DelveInsight’s expert analysis @ Biliary Tract Cancer Market Drivers and Barriers

Scope of the Biliary Tract Cancer Pipeline Report

  • Coverage- Global
  • Biliary Tract Cancer Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
  • Biliary Tract Cancer Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III
  • Biliary Tract Cancer Companies- Yantai Rongchang Pharmaceutical, RemeGen, EMD Serono, SMT bio Co., Ltd., CSPC ZhongQi Pharmaceutical Technology Co., Ltd., InnoPharmax Inc., Lee’s Pharmaceutical Limited, Hoffmann-La Roche, Shanghai Miracogen Inc., Zymeworks Inc., Bristol-Myers Squibb, Eli Lilly and Company, Ipsen, Threshold Pharmaceuticals, Leap Therapeutics, Hutchison Medipharma Limited, Array BioPharma, Redx Pharma Plc, Compass Therapeutics, Lee’s Pharmaceutical Limited, and others
  • Biliary Tract Cancer Therapies- Nivolumab, Gemcitabine, and S-1, Gemcitabine, cisplatin, Pembrolizumab, Sargramostim, oxaliplatin, KN035 plus Gemcitabine & oxaliplatin, and others.

Get the latest on Biliary Tract Cancer therapies and clinical trials. Download DelveInsight’s in-depth pipeline report today! @ Biliary Tract Cancer Companies, Key Products and Unmet Needs

Table of Content

  1. Introduction
  2. Executive Summary
  3. Biliary Tract Cancer: Overview
  4. Pipeline Therapeutics
  5. Therapeutic Assessment
  6. Biliary Tract Cancer– DelveInsight’s Analytical Perspective
  7. Late Stage Products (Phase III)
  8. Envafolimab: Alphamab Oncology
  9. Drug profiles in the detailed report…..
  10. Mid Stage Products (Phase II/III)
  11. SMT-NK: SMT bio Co., Ltd.
  12. Drug profiles in the detailed report…..
  13. Mid Stage Products (Phase II)
  14. HA121-28: CSPC ZhongQi Pharmaceutical Technology
  15. Drug profiles in the detailed report…..
  16. Early Stage Products (Phase I)
  17. ZKAB001: Lee’s Pharmaceutical Limited
  18. Drug profiles in the detailed report…..
  19. Preclinical and Discovery Stage Products
  20. Drug name: Company name
  21. Drug profiles in the detailed report…..
  22. Inactive Products
  23. Biliary Tract Cancer Key Companies
  24. Biliary Tract Cancer Key Products
  25. Biliary Tract Cancer- Unmet Needs
  26. Biliary Tract Cancer- Market Drivers and Barriers
  27. Biliary Tract Cancer- Future Perspectives and Conclusion
  28. Biliary Tract Cancer Analyst Views
  29. Biliary Tract Cancer Key Companies
  30. Appendix 

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Media Contact
Company Name: DelveInsight LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: +14699457679
Address:304 S. Jones Blvd #2432,
City: Las Vegas
State: United States
Country: India
Website: https://www.delveinsight.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Biliary Tract Cancers Pipeline 2024 | Yantai Rongchang Pharmaceutical, RemeGen, EMD Serono, SMT bio Co., Ltd., CSPC ZhongQi Pharmaceutical Technology Co., Ltd., InnoPharmax Inc., Lee\’s Pharmaceutical

Cell Expansion Market worth $26.7 billion by 2029

“Asia Pacific is anticipated to register fastest growth in the cell expansion owing to the increasing research practices in the field of advanced therapies such as tissue engineering and regenerative medicine, high government investments & fundings for R&D, and growing biotechnology industries.”
Browse 923 market data Tables and 54 Figures spread through 629 Pages and in-depth TOC on “Cell Expansion Market by Product (Consumables (Media, Sera, Reagents, Vessels), Equipment (Cell Expansion Systems, Bioreactors, Incubators)), Cell Type (Human, Animal (CHO, mESCs)), Application (Vaccines, mAbs, CGT), End User – Global Forecast to 2029

Cell Expansion Market in terms of revenue was estimated to be worth $14.3 billion in 2024 and is poised to reach $26.7 billion by 2029, growing at a CAGR of 13.3% from 2024 to 2029 according to a new report by MarketsandMarkets™. Some factors contributing to the growth of the global market includes increasing R&D investments in cell based research, growing focus on personalized medicine, and increasing number of strategic alliances for the development of novel therapeutics. However, ethical concern regarding cell biology and high cost of cell-based therapeutics are expected to hinder market growth.

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=194978883

 

The consumables segment accounted for the largest share of the product segment in the cell expansion market in 2023.

Based on products, the cell expansion market is segmented into consumables and equipment. Consumables segment dominated the market in 2023 and is expected to dominate the market in the forecast period. Consumables are further segmented into media, reagents, sera, vessels, and other consumables. The largest share of the segment is attributed to increasing research activities for the development of novel biopharmaceuticals.

The biopharmaceutical production segment is estimated to register the highest growth rate during the forecast period in the cell expansion market.

Based on application, the cell expansion market is segmented into biopharmaceutical production, tissue engineering & regenerative medicine, drug screening & development, and other applications. The biopharmaceutical production segment is estimated to register the highest growth rate during the forecast period. The rising demand for biopharmaceuticals such as vaccine, monoclonal antibodies, and therapeutic proteins due to increasing incidence of chronic diseases is anticipated to promote the growth of biopharmaceutical production segment in coming years.

The Asia Pacific region is the fastest-growing region of the cell expansion market in 2023.

Based on the region, the cell expansion market is segmented into major regions: North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. The Asia Pacific is anticipated to register fastest growth in the cell expansion owing to the increasing research practices in the field of advanced therapies such as tissue engineering and regenerative medicine, high government investments & fundings for R&D, and growing biotechnology industries.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=194978883

Cell Expansion Market Dynamics:

Drivers:

  1. Increasing incidence of chronic diseases
  2. Government investments for cell-based research
  3. Growing focus on personalized medicine
  4. Increasing focus on R&D for cell-based therapies
  5. Increasing GMP certifications for cell therapy production facilities

Restraints:

  1. Ethical concerns regarding research in cell biology

Opportunities:

  1. Emerging markets

Challenge:

  1. Growth opportunities in emerging markets

Key Market Players of Cell Expansion Industry:

Key players in the cell expansion market include Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), Merck KGaA (Germany), Sartorius AG (Germany), Corning Incorporated (US), Lonza (Switzerland), Terumo Corporation (Japan), Eppendorf SE (Germany), FUJIFILM Corporation (Japan), Bio-Techne (US), Repligen Corporation (US), Getinge AB (Sweden), Miltenyi Biotec (Germany), PerkinElmer Inc. (US), STEMCELL Technologies (Canada), PromoCell GmBH (Germany), HiMedia Laboratories (India), BD (US), Takara Bio Inc. (Japan), Shanghai Duoning Biotechnology Co., Ltd. (Japan), REPROCELL Inc. (Japan), PBS Biotech, Inc. (US), ACROBiosystems (US), Solida Biotech GmBH (Germany), Beijing CytoNiche Biotechnology Co., Ltd. (China), Neuromics (US), Bionet (Spain), and Cellexus (UK).

The primary interviews conducted for this report can be categorized as follows:

  • By Respondent: Supply Side- 60% and Demand Side 40%
  • By Designation: Managers – 55%, CXO & Directors – 20%, and Executives – 25%
  • By Region: North America – 40%, Europe -25%, Asia-Pacific -25%, Latin America -5% and Middle East & Africa- 5%

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=194978883

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Aashish Mehra
Email: Send Email
Phone: 18886006441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL 60062
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/cell-expansion-market-194978883.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Cell Expansion Market worth $26.7 billion by 2029

DNA Data Storage Market worth $3,348 Million by 2030, at a CAGR of 87.7%

“DNA Data Storage Market”
The global DNA Data Storage Market in terms of revenue was estimated to be worth $76 million in 2024 and is poised to reach $3348 million by 2030, growing at a CAGR of 87.7% during the forecast period.

The report “DNA Data Storage Market by Type (Cloud, On-Premises), Technology (Sequence-based DNA Data Storage, Structure-based DNA Data Storage), End Users (Government, Healthcare & Biotechnology, Media & Telecommunication) and Geography – Global Forecast to 2030” The DNA Data storage market is projected to grow from USD 76 million in 2024 and is expected to reach USD 3,348 million by 2030, growing at a CAGR of 87.7% from 2024 to 2030.

The growing threat of cyberattacks is one of the key factors driving the demand for DNA data storage. Cyberattacks are becoming increasingly sophisticated and frequent, and traditional data storage methods are vulnerable to attack. DNA data storage offers a more secure way to store data, making it less vulnerable to cyberattacks. DNA data storage mitigates the risk of large-scale data breaches, as physical access to the DNA sample is required for any kind of data retrieval, making it significantly more secure than digital databases.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=68300978

Browse 105 market data Tables and 51 Figures spread through 163 Pages and in-depth TOC on “DNA Data Storage Market by Type (Cloud, On-Premises), Technology (Sequence-based DNA Data Storage, Structure-based DNA Data Storage), End Users (Government, Healthcare & Biotechnology, Media & Telecommunication) and Geography – Global Forecast to 2030”

View detailed Table of Content here https://www.marketsandmarkets.com/Market-Reports/dna-data-storage-market-68300978.html

Cloud based DNA data storage to hold the largest share of the DNA data storage market during the forecast period.

Cloud-based DNA data storage involves storing digital information in the form of synthesized DNA strands within cloud computing environments. This innovative approach to data storage leverages the unique properties of DNA, such as its incredible data density and longevity, to store vast amounts of information in a highly compact and durable form. Overall, cloud-based DNA data storage holds immense potential for fields requiring vast and secure data storage, including genomics research, personalized medicine, and historical/archival data preservation. As technology advances and costs decrease, this approach is expected to become increasingly prevalent, shaping the future of data storage in the digital age.

Market for Healthcare and biotechnology segment is expected to account for largest market share during the forecast period.

The healthcare and biotechnology segment in the DNA data storage market is expected to hold the largest market size during the forecast period. Healthcare and biotechnology sectors generate vast volumes of genetic data, research findings, and sensitive patient information. DNA data storage enables the secure and compact storage of extensive genomic data sets. This is crucial for research on diseases, genetic mutations, and personalized medicine, allowing scientists and clinicians to analyze vast genetic information efficiently, enhancing healthcare facilities.

Sequence-based DNA data storage segment is expected to be the fastest growing market of the DNA data storage market during the forecast period.

Sequence-based DNA data storage is a type of DNA data storage in which data is encoded in the sequence of DNA bases. Currently, most of the companies active in DNA data storage market such as Catalog (US), and Twist Bioscience (US) are working on this technology. Both sequence-based and structure-based DNA data storage technologies have their own advantages and disadvantages. Higher capacity and more scalabilities are expected to be the two key advantages of sequence-based DNA data storage over structure-based DNA data storage. However, sequence-based DNA data storage is expected to be less durability and more expensive in comparison to structure-based DNA data storage.

North America to have the largest share of DNA data storage market in during the forecast period.

The North American region is expected to have the largest market share of the DNA data storage market during the forecast period. North America, particularly the United States, is home to numerous research institutions, universities, and biotechnology companies at the forefront of DNA data storage research and development. Investments in R&D activities aimed at enhancing DNA synthesis, sequencing, and storage technologies are likely to drive market growth in this region.

Leading players in the DNA data storage market include Illumina, Inc. (US), Microsoft (US), Iridia, Inc. (US), Twist Bioscience (US), Catalog (US), Thermo Fisher Scientific Inc. (US), Micron Technology, Inc. (US) Helixworks Technologies Ltd (Ireland), Agilent Technologies, Inc. (US), Beckman Coulter (US), Eurofins Scientific (Luxembourg) Siemens (Germany) and Oxford Nanopore Technologies (UK), Evonetix (UK), Quantum Corporation (US), Molecular Assemblies (US), BGI GROUP GUANGDONG ICP (China)are few other key companies operating in the DNA data storage market.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL 60062
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/dna-data-storage-market-68300978.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: DNA Data Storage Market worth $3,348 Million by 2030, at a CAGR of 87.7%

BMTEX Exchange: Leading Cryptocurrency Trading Platform Offering Lightning-Fast Experience and Comprehensive Financial Services

The brand-new cryptocurrency trading platform, BMTEX, has launched with a bang, providing global users with a lightning-fast trading experience and a full range of financial services.

BMTEX Exchange, an all-encompassing cryptocurrency trading platform, integrates spot trading, contract trading, C2C trading, financial services, and mining pools. Recently opened to users worldwide, BMTEX is quickly becoming a shining star in the cryptocurrency trading arena thanks to its robust technical capabilities, extensive features, and commitment to optimizing user experience.

Diverse Features to Meet Varied Trading Needs

BMTEX offers users a variety of trading options, including spot trading, perpetual and futures contract trading, and C2C trading, catering to different trading preferences and strategy requirements. Whether you are a spot trader seeking short-term gains or an experienced investor looking to leverage returns through contract trading, BMTEX has the right trading method for you.

In addition to trading services, BMTEX provides a range of financial services, including fund management and investment services, helping users achieve stable asset growth. Moreover, BMTEX boasts a powerful mining pool that offers higher mining returns, contributing to the flourishing development of the cryptocurrency ecosystem.

Lightning-Fast Experience with Millisecond Trading

BMTEX understands the importance of trading speed for users and has spared no effort in platform design. Leveraging years of user operation experience and millisecond-level core memory matching technology, BMTEX has created an ultra-smooth trading interface, making trading more convenient and comfortable than ever.

Safety First with Multiple Safeguards

In the cryptocurrency trading field, security is always a top concern for users. BMTEX recognizes this and has implemented multiple security measures to ensure the safety of users’ assets and information. All fund movements are completed through multi-signature offline processes, effectively preventing hacker attacks and fund theft. Additionally, BMTEX employs comprehensive contract currency price algorithms and robust risk control capabilities to effectively mitigate risks from market fluctuations, ensuring the safety of users’ investments.

Top-Notch Technology and Professional Team

BMTEX boasts a top-tier technical team of blockchain technology experts who not only ensure the stable operation and security of the platform but also continuously drive technological innovation and feature upgrades, delivering a superior trading experience to users.

Tiered Mitigation Mechanism for Around-the-Clock Protection

BMTEX’s unique tiered mitigation mechanism triggers appropriate trading risk control measures based on changing market conditions, providing 24/7 protection for users’ assets. Even in highly volatile markets, users can trade with peace of mind, without worrying about asset losses.

24/7 Customer Service with Attentive Support

BMTEX implements a 24/7 customer service schedule, offering professional and efficient assistance and support anytime, anywhere. Whether you have trading issues, technical inquiries, or other questions, users can receive satisfactory answers promptly.

 

BMTEX: Your Preferred Cryptocurrency Trading Platform

With its rich features, lightning-fast trading experience, comprehensive security measures, top-notch technical support, and attentive customer service, BMTEX is rapidly gaining favor among global users. Whether you are a novice in cryptocurrency trading or an experienced investor, BMTEX is the best choice for starting your cryptocurrency trading journey.

Join BMTEX now and begin a new chapter in your cryptocurrency trading!

Disclaimer: This press release may contain forward-looking statements. Forward-looking statements describe future expectations, plans, results, or strategies (including product offerings, regulatory plans and business plans) and may change without notice. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements.

Media Contact
Company Name: BMTEX Exchange
Contact Person: Sara
Email: Send Email
Country: Singapore
Website: https://www.bitdgcpc.com